Multi-target-Directed Ligands To Combat Neurodegenerative Diseases

Cited by (1,000)

Items 601–700 of 1,000

1. 8-Substituted 1,3-dimethyltetrahydropyrazino[2,1-f]purinediones: Water-soluble adenosine receptor antagonists and monoamine oxidase B inhibitors
   Andreas Brunschweiger, Pierre Koch, Miriam Schlenk, Muhammad Rafehi, Hamid Radjainia, Petra Küppers, Sonja Hinz, Felipe Pineda, Michael Wiese, Jörg Hockemeyer et al. · 2016 · Bioorganic & Medicinal Chemistry
2. A new multifunctional hydroxytyrosol-fenofibrate with antidiabetic, antihyperlipidemic, antioxidant and antiinflammatory action
   Yundong Xie, Yan-Hong Xu, Zizhang Chen, Wen-Fang Lu, Na Li, Qiutang Wang, Lihua Shao, Yiping Li, Guangde Yang, Xiaoli Bian · 2017 · Biomedicine & Pharmacotherapy
3. Tacrines as Therapeutic Agents for Alzheimer's Disease. IV. The Tacripyrines and Related Annulated Tacrines
   Manuela Bartolini, Jose Luis Marco · 2018 · The Chemical Record
4. Combination of Memantine and 6-Chlorotacrine as Novel Multi-Target Compound against Alzheimer’s Disease
   Martina Kaniaková, Eugenie Nepovimová, Lenka Kletečková, Kristýna Skřenková, Kristína Holubová, Žofia Chrienová, Vendula Hepnarová, Tomas Kucera, Tereza Kobrlová, Karel Valeš et al. · 2019 · Current Alzheimer Research
5. Novel multi target-directed ligands targeting 5-HT4 receptors with in cellulo antioxidant properties as promising leads in Alzheimer's disease
   Caroline Lanthier, Hugo Payan, Irene Liparulo, Bérénice Hatat, Cédric Lecoutey, Marc Since, Audrey Davis, Christian Bergamini, Sylvie Claeysen, Patrick Dallemagne et al. · 2019 · European Journal of Medicinal Chemistry
6. Turning Donepezil into a Multi‐Target‐Directed Ligand through a Merging Strategy
   Rosaria Carmela Perone, Claudia Albertini, Elisa Uliassi, Flaminia Di Pietri, Pedro de Sena Murteira Pinheiro, Sabrina Petralla, Nicola Rizzardi, Romana Fato, Lenka Pulkrabkova, Ondřej Soukup et al. · 2020 · ChemMedChem
7. CADMA-Chem: A Computational Protocol Based on Chemical Properties Aimed to Design Multifunctional Antioxidants
   Eduardo Gabriel Guzmán‐López, Miguel Reina, Adriana Pérez‐González, Misaela Francisco‐Márquez, Luis Felipe Hernández‐Ayala, Romina Castañeda‐Arriaga, Annia Galano · 2022 · International Journal of Molecular Sciences
8. BACE-1 Inhibitors Targeting Alzheimer's Disease
   Kadja Luana Chagas Monteiro, Marcone Gomes dos Santos Alcântara, Nathalia Monteiro Lins Freire, Esaú Marques Brandão, Vanessa Lima do Nascimento, Líbni Maísa dos Santos Viana, Thiago Mendonça de Aquino, Edeildo Ferreira da Silva‐Júnior · 2023 · Current Alzheimer Research
9. Predicting targets of compounds against neurological diseases using cheminformatic methodology
   Katarina M. Nikolic, Lazaros Mavridis, Óscar M. Bautista‐Aguilera, José Marco‐Contelles, Holger Stark, M. Carmo Carreiras, Ilaria Rossi, Paola Massarelli, Danica D. Agbaba, Rona Ruth Ramsay et al. · 2014 · Journal of Computer-Aided Molecular Design
10. M1 muscarinic cetylcholine receptor allosteric modulators as potential therapeutic opportunities for treating Alzheimer's disease
    Michael W. Decker, Ulrike Holzgrabe · 2012 · MedChemComm
11. 3-Aryl-1-phenyl-1H-pyrazole derivatives as new multitarget directed ligands for the treatment of Alzheimer's disease, with acetylcholinesterase and monoamine oxidase inhibitory properties
    Ashwani Kumar, Sandeep Jain, Milind Parle, Jain, Neelam, Prof Parvin Kumar · 2013 · EXCLI journal
12. Acetylcholinesterase Inhibitors of Natural Origin
    Melanie‐Jayne R. Howes, Peter John Houghton · 2009
13. Synthesis and pharmacological evaluation of multi-functional homoisoflavonoid derivatives as potent inhibitors of monoamine oxidase B and cholinesterase for the treatment of Alzheimer's disease
    Qiaohong Liu, Jia‐Jia Wu, Fan Li, Pei Cai, Xuelian Yang, Ling‐Yi Kong, Xiaobing Wang · 2017 · MedChemComm
14. One Drug for Multiple Targets: A Computational Perspective
    Oscar Méndez‐Lucio, J. Jesús Naveja, Hugo Vite‐Caritino, Fernando Daniel Prieto-Martínez, José L. Medina‐Franco · 2017 · Journal of the Mexican Chemical Society
15. Extended Multitarget Pharmacology of Anticancer Drugs
    Da Shi, Feroz Khan, Ruben A Abagyan · 2019 · Journal of Chemical Information and Modeling
16. Challenges in Designing Therapeutic Agents for Treating Alzheimer’s Disease-from Serendipity to Rationality
    Umer Rashid, Farzana Latif Ansari · 2014 · Elsevier eBooks
17. New Multifunctional Di-tert-butylphenoloctahydro(pyrido/benz)oxazine Derivatives with Antioxidant, Antihyperlipidemic, and Antidiabetic Action
    Eleni M. Ladopoulou, Alexios N. Matralis, Angeliki P. Kourounakis · 2013 · Journal of Medicinal Chemistry
18. A novel acetylcholinesterase inhibitor and calcium channel blocker SCR-1693 improves Aβ25–35-impaired mouse cognitive function
    Zhengping Zhang, Rong Chen, Wenji An, Chunmei Wang, Gaoyong Liao, Xiaoliang Dong, Aijing Bi, Zhimin Yin, Lan Luo · 2015 · Psychopharmacology
19. Quebrachitol: Global Status and Basic Research
    Dong Wang, Shuqun Zhang, Zhe Chang, Kong De, Zhili Zuo · 2017 · Natural Products and Bioprospecting
20. Phenylpropanoids and lignans from Prunus tomentosa seeds as efficient β-amyloid (Aβ) aggregation inhibitors
    Qingbo Liu, Jie Wang, Bin Lin, Zhuo-Yang Cheng, Ming Bai, Shao-Chun Shi, Xiao‐Xiao Huang, Shao‐Jiang Song · 2018 · Bioorganic Chemistry
21. Design, synthesis and biological evaluation of potential anti-AD hybrids with monoamine oxidase B inhibitory and iron-chelating effects
    Jianan Guo, Zhisheng Mi, Xiaoying Jiang, Changjun Zhang, Zili Guo, Lin-Zi Li, Jinping Gu, Tao Zhou, Renren Bai, Yuanyuan Xie · 2020 · Bioorganic Chemistry
22. Histamine H3 receptor and cholinesterases as synergistic targets for cognitive decline: Strategies to the rational design of multitarget ligands
    Flávia Barrio Lopes, Cecília M. S. Q. Aranha, João Paulo S. Fernandes · 2021 · Chemical Biology & Drug Design
23. Cyanobiphenyls: Novel H3 receptor ligands with cholinesterase and MAO B inhibitory activity as multitarget compounds for potential treatment of Alzheimer’s disease
    Justyna Godyń, Paula Zaręba, Dorota Łażewska, Dorota Stary, David Reiner‐Link, Annika Frank, Gniewomir Latacz, Szczepan Mogilski, Maria Kaleta, Agata Doroż-Płonka et al. · 2021 · Bioorganic Chemistry
24. Therapeutic strategies for identifying small molecules against prion diseases
    Elisa Uliassi, Lea Nikolić, María Laura Bolognesi, Giuseppe Legname · 2022 · Cell and Tissue Research
25. Development of naringenin-O-carbamate derivatives as multi-target-directed liagnds for the treatment of Alzheimer’s disease
    Jing Mi, Ying He, Jing Yang, Yi Zhou, Gaofeng Zhu, Anguo Wu, Wenmin Liu, Zhipei Sang · 2022 · Bioorganic & Medicinal Chemistry Letters
26. Design, synthesis and evaluation of novel scutellarin and scutellarein-N,N-bis-substituted carbamate-l-amino acid derivatives as potential multifunctional therapeutics for Alzheimer’s disease
    Dirong Wu, Jiao Chen, Keke Luo, Hui Li, Ting Liu, Li Li, Zeqin Dai, Yongjun Li, Yong‐Long Zhao, Xiao‐Zhong Fu · 2022 · Bioorganic Chemistry
27. Riluzole–Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis
    Claudia Albertini, Alessandra Salerno, Silvia Atzeni, Elisa Uliassi, Francesca Massenzio, Annalisa Maruca, Roberta Rocca, Marko Mecava, Filomena S. G. Silva, Débora Mena et al. · 2022 · ACS Chemical Neuroscience
28. New Indole Derivatives As Multitarget anti-Alzheimer's Agents: synthesis, Biological Evaluation and Molecular Dynamics
    Eman M. Azmy, Ibrahim F. Nassar, Mohamed Hagras, Iten M. Fawzy, Maghawry Hegazy, Mahmoud Mohamed Mokhtar, Amr Mohamed Yehia, Nasser S. M. Ismail, Walaa H. Lashin · 2023 · Future Medicinal Chemistry
29. Design, synthesis, and biological evaluation of 1,2,4-oxadiazole-based derivatives as multitarget anti-Alzheimer agents
    Mohammed Salah Ayoup, Mohamed Reda Barakat, Hamida Abdel‐Hamid, Ehab Emam, Yasair Suliman Al-Faiyz, Aliaa A. Masoud, Doaa Ahmad Ghareeb, Amr Sayed Motawi Sonousi, Asmaa E. Kassab · 2024 · RSC Medicinal Chemistry
30. Design, synthesis, in vitro and in silico evaluations of new isatin-triazine- aniline hybrids as potent anti- Alzheimer multi-target directed lead compounds
    Yasaman Tamaddon-Abibigloo, Siavoush Dastmalchi, Nima Razzaghi‐Asl, Javid Shahbazi Mojarrad · 2024 · Bioorganic Chemistry
31. Identification of a Lacosamide Binding Protein Using an Affinity Bait and Chemical Reporter Strategy: 14-3-3 ζ
    Ki Duk Park, Dong‐Wook Kim, Onrapak Reamtong, Claire E. Eyers, Simon J. Gaskell, Rihe Liu, Harold Kohn · 2011 · Journal of the American Chemical Society
32. Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer’s disease therapy
    Youssef Dgachi, Hélène Martin, R.S. Malek, Daniel Jun, Jana Janočková, Vendula Šepsová, Ondřej Soukup, Isabel Iriepa, Ignacio Moraleda, Emna Maalej et al. · 2018 · Journal of Enzyme Inhibition and Medicinal Chemistry
33. Design, synthesis and biological evaluation of edaravone derivatives bearing the N -benzyl pyridinium moiety as multifunctional anti-Alzheimer’s agents
    Luke S. Zondagh, Sarel F. Malan, Jacques Joubert · 2020 · Journal of Enzyme Inhibition and Medicinal Chemistry
34. Discovery of new scaffolds from approved drugs as acetylcholinesterase inhibitors
    Yao Chen, Xiaoli Xu, Tingming Fu, Wei Li, Zongliang Liu, Haopeng Sun · 2015 · RSC Advances
35. Multigram Synthesis and in Vivo Efficacy Studies of a Novel Multitarget Anti-Alzheimer’s Compound
    Irene Sola, Elisabet Viayna, Tània Gómez, Carles Galdeano, Matteo Cassina, Pelayo Camps, Margherita Romeo, Luisa Diomede, Mario Salmona, Pilar Franco et al. · 2015 · Molecules
36. Additional acetyl cholinesterase inhibitory property of diaryl pyrazoline derivatives
    Nibha Mishra, Dinakar Sasmal · 2012 · Bioorganic & Medicinal Chemistry Letters
37. Design, Synthesis and Biological Evaluation of New Antioxidant and Neuroprotective Multitarget Directed Ligands Able to Block Calcium Channels
    Irène Pachón-Angona, Solene Daniel, Hélène Martin, Alexandre Bonet, Artur Wnorowski, Maciej Maj, Krzysztof Jóźwiak, Tiago Silva, Bernard Refouvelet, Fernanda Borges et al. · 2020 · Molecules
38. From Kinase Inhibitors to Multitarget Ligands as Powerful Drug Leads for Alzheimer's Disease using Protein‐Templated Synthesis
    Vanesa Nozal, Alfonso García‐Rubia, Eva P. Cuevas, Concepción Pérez, Carlota Tosat‐Bitrián, Fernando Benito Bartolomé, Eva Carro, David Ramírez, Valle Palomo, Ana Martı́nez · 2021 · Angewandte Chemie International Edition
39. First-in-Class Isonipecotamide-Based Thrombin and Cholinesterase Dual Inhibitors with Potential for Alzheimer Disease
    Rosa Purgatorio, Nicola Gambacorta, Modesto de Candia, Marco Catto, Mariagrazia Rullo, Leonardo Pisani, Orazio Nicolotti, Cosimo Altomare · 2021 · Molecules
40. Cryptotanshinone Alleviates Oxidative Stress and Reduces the Level of Abnormally Aggregated Protein in Caenorhabditis elegans AD Models
    Wen-Bo Cui, Zongping Zhang, Xue Bai, Shanshan Wang, Xiaohan Chen, Xu Liu, Pan‐Jie Su, Dejuan Zhi, Dong‐Qing Fei, Zhan‐Xin Zhang et al. · 2022 · International Journal of Molecular Sciences
41. Practical Three-Component Regioselective Synthesis of Drug-Like 3-Aryl(or heteroaryl)-5,6-dihydrobenzo[h]cinnolines as Potential Non-Covalent Multi-Targeting Inhibitors To Combat Neurodegenerative Diseases
    Hossein Mousavi, Mehdi Rimaz, Behzad Zeynizadeh · 2024 · ACS Chemical Neuroscience
42. Advances in dual-targeting inhibitors of HDAC6 for cancer treatment
    Zhicheng Gu, Shuxian Lin, Junhui Yu, Fei Jin, Qingqing Zhang, Keli Xia, Lei Chen, Yan Li, Bin He · 2024 · European Journal of Medicinal Chemistry
43. Rational drug discovery design approaches for treating Parkinson’s disease
    Cornelis J. Van der Schyf · 2015 · Expert Opinion on Drug Discovery
44. Multi-target novel neuroprotective compound ITH33/IQM9.21 inhibits calcium entry, calcium signals and exocytosis
    Marcos Maroto, Antonio M. G. de Diego, E. Albiñana, José‐Carlos Fernández‐Morales, Afonso Caricati‐Neto, Aron Jurkiewicz, Matilde Yáñez, Marı́a Isabel Rodrı́guez-Franco, Santiago Conde, Mariana P. Arce et al. · 2011 · Cell Calcium
45. Biological Activity of sym-Triazines with Acetylcholine-like Substitutions as Multitarget Modulators of Alzheimer’s Disease
    Anthony J. Veloso, Ari M. Chow, Devjani Dhar, Derek W.F. Tang, Hashwin V. S. Ganesh, Svetlana N. Mikhaylichenko, Ian R. Brown, Kağan Kerman · 2013 · ACS Chemical Neuroscience
46. Computational Study of the Aza‐Michael Addition of the Flavonoid (+)‐Taxifolin in the Inhibition of β‐Amyloid Fibril Aggregation
    Tiziana Ginex, Marta Trius‐Soler, Francisco Javier Luque · 2018 · Chemistry - A European Journal
47. Compound CID 9998128 Is a Potential Multitarget Drug for Alzheimer’s Disease
    Nguyen Quoc Thai, Zuzana Bednáriková, Miroslav Gančár, Huynh Quang Linh, Chin‐Kun Hu, Mai Suan Li, Zuzana Gažová · 2018 · ACS Chemical Neuroscience
48. Conjugates of Tacrine with Salicylamide as Promising Multitarget Agents for Alzheimer's Disease
    Maria V. Grishchenko, Галина Ф. Махаева, Yanina V. Burgart, Елена Владимировна Рудакова, Natalia P. Boltneva, Надежда Владимировна Ковалева, Olga G. Serebryakova, Sofya V. Lushchekina, T. Yu. Astakhova, Ekaterina F. Zhilina et al. · 2022 · ChemMedChem
49. In silico Target Fishing for the Potential Targets and Molecular Mechanisms of Baicalein as an Antiparkinsonian Agent: Discovery of the Protective Effects on NMDA Receptor‐Mediated Neurotoxicity
    Li Gao, Jiansong Fang, Xiaoyu Bai, Dan Zhou, Yitao Wang, Ailin Liu, Guanhua Du · 2013 · Chemical Biology & Drug Design
50. 1,8-Naphthyridine derivatives as Cholinesterases Inhibitors and Cell Ca2+ Regulators, a Multitarget Strategy for Alzheimer's Disease
    Javier Egea, Cristóbal de los Rı́os · 2011 · Current Topics in Medicinal Chemistry
51. Targeting alpha synuclein and amyloid beta by a multifunctional, brain-penetrant dopamine D2/D3 agonist D-520: Potential therapeutic application in Parkinson’s disease with dementia
    Deepthi Yedlapudi, Liping Xu, Dan Luo, G. Marsh, Sokol V. Todi, Aloke K. Dutta · 2019 · Scientific Reports
52. Multitarget-directed Ligands for Neurodegenerative Diseases: Real Opportunity Or Blurry mirage?
    Mohamed Benchekroun, Samuele Maramai · 2019 · Future Medicinal Chemistry
53. Scaffold Hybridization Strategy Leads to the Discovery of Dopamine D 3 Receptor-Selective or Multitarget Bitopic Ligands Potentially Useful for Central Nervous System Disorders
    Alessandro Bonifazi, Amy Hauck Newman, Thomas M. Keck, Silvia I. Gervasoni, Giulio Vistoli, Fabio Del Bello, Gianfabio Giorgioni, Pegi Pavletić, Wilma Quaglia, Alessandro Piergentili · 2021 · ACS Chemical Neuroscience
54. Development of naringenin- O -alkylamine derivatives as multifunctional agents for the treatment of Alzheimer’s disease
    Jing Yang, Yi Ming Zhou, Yujuan Ban, Jing Mi, Ying He, Xinjuan Li, Zhengwei Liu, Keren Wang, Gaofeng Zhu, Wenmin Liu et al. · 2022 · Journal of Enzyme Inhibition and Medicinal Chemistry
55. The Use of Zidovudine Pharmacophore in Multi-Target-Directed Ligands for AIDS Therapy
    Maria da Conceição Avelino Dias Bianco, Débora Inácio Leite, Frederico Silva Castelo Branco, Núbia Boechat, Elisa Uliassi, María Laura Bolognesi, Mônica M. Bastos · 2022 · Molecules
56. Role of Natural Products in Combating Cancer
    Camilla Barreto, Alwjandra Jandus · 2022 · Cancer Insight
57. Design, Synthesis, and Proof of Concept of Balanced Dual Inhibitors of Butyrylcholinesterase (BChE) and Histone Deacetylase 6 (HDAC6) for the Treatment of Alzheimer’s Disease
    Lei Wang, Tian‐Yu Sun, Zhenqi Wang, Hui Liu, Weimin Qiu, Xu Tang, Huanchao Guo, Peng Yang, Chen Yao, Haopeng Sun · 2023 · ACS Chemical Neuroscience
58. In vitro and in silico correlation of bis-thiazole based Schiff base hybrids analogues: A computational approach develop to promising acetylcholinesterase and butyrylcholinesterase inhibitors
    Uzma Jehangir, Shoaib Khan, Rafaqat Hussain, Yousaf Khan, Fazal Rahim, Tayyiaba Iqbal, Tariq A. Aziz, Abdullah F. Alasmari · 2024 · Journal of Molecular Structure
59. Novel 6-alkyl-bridged 4-arylalkylpiperazin-1-yl derivatives of azepino[4,3-b]indol-1(2H)-one as potent BChE-selective inhibitors showing protective effects against neurodegenerative insults
    Francesco Samarelli, Rosa Purgatorio, Gianfranco Lopopolo, Caterina Deruvo, Marco Catto, Michael Andresini, Antonio Carrieri, Orazio Nicolotti, Annalisa De Palma, Daniela Valeria Miniero et al. · 2024 · European Journal of Medicinal Chemistry
60. Research and development of anti-Alzheimer’s drugs: an analysis based on technology flows measured by patent citations
    Jiachen Xu, Xiangjun Kong, Lan Qiu, Xiaomei Geng, Hu Yuanjia, Yitao Wang · 2014 · Expert Opinion on Therapeutic Patents
61. Donepezil-based hybrids as multifunctional anti-Alzheimer's disease chelating agents: Effect of positional isomerization
    Marina Costa, Romane Josselin, Diana Filipa Silva, Sandra M. Cardoso, Nóra V. May, Sı́lvia Chaves, Maria Amélia Santos · 2020 · Journal of Inorganic Biochemistry
62. Novel benzylidenephenylpyrrolizinones with pleiotropic activities potentially useful in Alzheimer's disease treatment
    Jean‐Pierre Jourdan, Marc Since, Laïla El Kihel, Cédric Lecoutey, Sophie Corvaisier, Rémi Legay, Jana Sopková‐de Oliveira Santos, Thierry Cresteil, Aurélie Malzert‐Fréon, Christophe Rochais et al. · 2016 · European Journal of Medicinal Chemistry
63. Multitarget 1,4-Dioxane Compounds Combining Favorable D 2 -like and 5-HT 1A Receptor Interactions with Potential for the Treatment of Parkinson’s Disease or Schizophrenia
    Fabio Del Bello, Dario Ambrosini, Alessandro Bonifazi, Amy Hauck Newman, Thomas M. Keck, Mario Giannella, Gianfabio Giorgioni, Alessandro Piergentili, Loredana Cappellacci, Antonio Cilia et al. · 2019 · ACS Chemical Neuroscience
64. Design and Synthesis of Novel Tacrine–Indole Hybrids As Potential Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease
    Slávka Hamuľaková, Z Kudlicková, Ladislav Janovec, Roman Mezencev, Zachery J. Deckner, Yury O. Chernoff, Jana Janočková, Veronika Ihnatova, Petr Bzonek, Nikola Novakova et al. · 2021 · Future Medicinal Chemistry
65. Discovery of 7-O-1, 2, 3-triazole hesperetin derivatives as multi-target-directed ligands against Alzheimer's disease
    Min Wang, Longji Fang, Tongtong Liu, Xuejie Chen, Yan Hua Zheng, Yilong Zhang, Shiming Chen, Zeng Li · 2021 · Chemico-Biological Interactions
66. Novel Coumarin–Pyridine Hybrids as Potent Multi-Target Directed Ligands Aiming at Symptoms of Alzheimer’s Disease
    Elaheh Babaei, Tuba Tüylü Küçükkılınç, Leili Jalili‐Baleh, Hamid Nadri, Esin Öz, Hamid Forootanfar, Elaheh Hosseinzadeh, Tayebeh Akbari, Mehdi Shafiee Ardestani, Loghman Firoozpour et al. · 2022 · Frontiers in Chemistry
67. HDAC/JAK dual target inhibitors of cancer-related targets: The success of nonclearable linked pharmacophore mode
    Liyun Zhao, Qi Liang, Ye He, Maoyu Liu, Rongsheng Tong, Zhongliang Jiang, Wenjing Wang, Jianyou Shi · 2022 · Bioorganic Chemistry
68. Meserine, a Novel Carbamate AC hE Inhibitor, Ameliorates Scopolamine‐Induced Dementia and Alleviates Amyloidogenesis of APP / PS 1 Transgenic Mice
    Bi‐Yun Shao, Zheng Xia, Qiong Xie, Xin-xing Ge, Weiwei Zhang, Jian Sun, Pan Jiang, Hao Wang, Weidong Le, Zhuibai Qiu et al. · 2013 · CNS Neuroscience & Therapeutics
69. Simply combining fasudil and lipoic acid in a novel multitargeted chemical entity potentially useful in central nervous system disorders
    Meihui Chen, Qi Liu, Anmin Liu, Min Tan, Zhi Xie, Asko Uri, Ziwei Chen, Guangye Huang, Yang Sun, Ge Hu et al. · 2014 · RSC Advances
70. Insights into the Impact of a Membrane-Anchoring Moiety on the Biological Activities of Bivalent Compounds As Potential Neuroprotectants for Alzheimer’s Disease
    He Liu, Yuqi Jiang, Kai Liu, Victoria Gómez‐Murcia, Xiaopin Ma, Alejandro Torrecillas, Qun Chen, Xiongwei Zhu, Edward Joseph Lesnefsky, Juan Carmelo Gómez-Fernández et al. · 2017 · Journal of Medicinal Chemistry
71. Multi-Target Drugs Against Metabolic Disorders
    Luciana Scotti, Alex Monteiro, Jéssika de Oliveira Viana, Francisco Jaime Bezerra Mendonça, Hamilton Mitsugu Ishiki, Nkwengoua Ernestine, Rodrigo Santos, Luciana Scotti · 2018 · Endocrine Metabolic & Immune Disorders - Drug Targets
72. Exploring beta amyloid cleavage enzyme‐1 inhibition and neuroprotective role of benzimidazole analogues as anti‐alzheimer agents
    Archana S. Gurjar, Vivek S. Solanki, Ankita R. Meshram, Suchita S. Vishwakarma · 2019 · Journal of the Chinese Chemical Society
73. From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects.
    Caterina Pont, Tiziana Ginex, C. Griñán-Ferré, M. Scheiner, Alexia Mattellone, Noemí Martínez, E. Arce, Yolanda Soriano-Fernández, M. Naldi, A. De Simone et al. · 2021 · European journal of medicinal chemistry
74. Synthesis of dual AChE/5-HT4 receptor multi-target directed ligands
    Cédric Lecoutey, Christophe Rochais, David Genest, Sabrina Butt‐Gueulle, Céline Ballandonne, Sophie Corvaisier, Fabienne Dulin, Alban Lepailleur, Jana Sopková‐de Oliveira Santos, Patrick Dallemagne · 2012 · MedChemComm
75. Synthesis of Thiazolo[5,4-f]quinazolin-9(8H)-ones as Multi-Target Directed Ligands of Ser/Thr Kinases
    Damien Hédou, Julien Godeau, Nadège Loaëc, Laurent Meijer, Corinne Fruit, Thierry Besson · 2016 · Molecules
76. Co-modulation of an allosteric modulator of nicotinic receptor-cholinesterase inhibitor (galantamine) and a 5-HT4 receptor agonist (RS-67333): effect on scopolamine-induced memory deficit in the mouse
    Thomas Fréret, Véronique Lelong‐Boulouard, Pierre Lecouflet, Katia Hamidouche, François Dauphin, Michel Boulouard · 2017 · Psychopharmacology
77. Evaluation of 2-amino-6-nitrobenzothiazole derived hydrazones as acetylcholinesterase inhibitors: in vitro assays, molecular docking and theoretical ADMET prediction
    Rati Kailash Prasad Tripathi, Senthil Raja Ayyannan · 2017 · Medicinal Chemistry Research
78. 4-tert-Pentylphenoxyalkyl derivatives – Histamine H3 receptor ligands and monoamine oxidase B inhibitors
    Dorota Łażewska, Agnieszka Olejarz‐Maciej, Maria Kaleta, Marek Bajda, Agata Siwek, Tadeusz P. Karcz, Agata Doroż-Płonka, Urszula Cichoń, Kamil Kuder, Katarzyna Kieć‐Kononowicz · 2018 · Bioorganic & Medicinal Chemistry Letters
79. Identification of ovalbumin-derived peptides as multi-target inhibitors of AChE, BChE and BACE1.
    Zhi-Peng Yu, Wanyi Dong, Si-Jia Wu, J. Shen, Wen-Zhu Zhao, Long Ding, Jing-Bo Liu, Fu-Ping Zheng · 2020 · The Journal of the Science of Food and Agriculture
80. Melatonin and the nervous system: nanomedicine perspectives
    Fucen Luo, Yuru Deng, Borislav Angelov, Angelina Angelova · 2025 · Biomaterials Science
81. Functional characterization of multifunctional ligands targeting acetylcholinesterase and alpha 7 nicotinic acetylcholine receptor
    Monika Cieslikiewicz‐Bouet, Marina Naldi, Manuela Bartolini, Belén Pérez, Denis Servent, Ludovic Jean, Rómulo Aráoz, Pierre‐Yves Renard · 2020 · Biochemical Pharmacology
82. Novel propargylamine-based inhibitors of cholinesterases and monoamine oxidases: Synthesis, biological evaluation and docking study
    Martin Krátký, Quynh Anh Vu, Šárka Štěpánková, Annalisa Maruca, Tiago Silva, Martin Ambrož, Václav Pflégr, Roberta Rocca, Katarína Svrčková, Stefano Alcaro et al. · 2021 · Bioorganic Chemistry
83. Designing Dual Inhibitors of Autotaxin-LPAR GPCR Axis
    Souvik Banerjee, Sue-Chin Lee, Derek D. Norman, Gábor Tigyi · 2022 · Molecules
84. Synthesis, biological evaluation and molecular docking study of oxindole based chalcone analogues as potent anti-Alzheimer agents
    Muhammad Taha, Haleema Sadia, Fazal Rahim, Mohammad Imran Khan, Shawkat Hayat, Naveed Iqbal, Faisal Nawaz, Hayat Ullah, Hussan Zada, Syed Adnan Alı Shah et al. · 2023 · Journal of Molecular Structure
85. A Review of the Development of Multitarget Molecules against HIV-TB Coinfection Pathogens
    Debora I. Leite, Stefany de Castro Bazan Moura, Avelino Dias Maria da Conceição, Carolina C. P. Costa, G. P. Machado, L. Pimentel, F. Branco, Rui Moreira, M. Bastos, N. Boechat · 2023 · Molecules
86. Design, Synthesis, and Biological Evaluation of Ferulic Acid Template-Based Novel Multifunctional Ligands Targeting NLRP3 Inflammasome for the Management of Alzheimer’s Disease
    Gourav Singh, Gauri Shankar, Samir Ranjan Panda, Sunil Kumar, Sanskriti Rai, Himanshu Verma, Prabhat Kumar, Prasanta Kumar Nayak, V.G.M. Naidu, Saripella Srikrishna et al. · 2024 · ACS Chemical Neuroscience
87. Pyranopyrazolotacrines as Nonneurotoxic, Aβ-Anti-Aggregating and Neuroprotective Agents for Alzheimer's Disease
    Mourad Chioua, Javier Pérez‐Peña, Nuria García-Font, Ignacio Moraleda, Isabel Iriepa, Elena Soriano, Jose Luis Marco, María Jesús Oset‐Gasque · 2015 · Future Medicinal Chemistry
88. Molecular perception of interactions between bis(7)tacrine and cystamine-tacrine dimer with cholinesterases as the promising proposed agents for the treatment of Alzheimer’s disease
    Mahboobeh Eslami, Seyed Majid Hashemianzadeh, Kowsar Bagherzadeh, Seyed Abolfazl Seyed Sajadi · 2015 · Journal of Biomolecular Structure and Dynamics
89. Synthesis of pterostilbene and resveratrol carbamate derivatives as potential dual cholinesterase inhibitors and neuroprotective agents
    Wenmin Yuan, Zhipei Shang, Xiaoming Qiang, Zhenghuai Tan, Yong Deng · 2013 · Research on Chemical Intermediates
90. Multidisciplinary approaches for targeting the secretase protein family as a therapeutic route for Alzheimer's disease
    Nalini Schaduangrat, Veda Prachayasittikul, Saowapak Choomwattana, Prapimpun Wongchitrat, Kamonrat Phopin, Wilasinee Suwanjang, Aijaz Ahmad Malik, Bruno Vincent, Chanin Nantasenamat · 2019 · Medicinal Research Reviews
91. From Hybrids to New Scaffolds: The Latest Medicinal Chemistry Goals in Multi-target Directed Ligands for Alzheimers Disease
    Jazmín Alarcón‐Espósito, Michael Mallea, Julio Rodríguez-Lavado · 2020 · Current Neuropharmacology
92. New Coumarin Derivatives as Cholinergic and Cannabinoid System Modulators
    Serena Montanari, Marco Allarà, Laura Scalvini, Magdalena Kostrzewa, Federica Belluti, Silvia Gobbi, Marina Naldi, Silvia Rivara, Manuela Bartolini, Alessia Ligresti et al. · 2021 · Molecules
93. The novel therapeutic strategy of vilazodone-donepezil chimeras as potent triple-target ligands for the potential treatment of Alzheimer's disease with comorbid depression
    Xiaokang Li, Jinwen Li, Yunyuan Huang, Qi Gong, Yan Fu, Yixiang Xu, Junyang Huang, Haolan You, Dong Zhang, Dan Zhang et al. · 2021 · European Journal of Medicinal Chemistry
94. Behavioral effects of D3 receptor inhibition and 5-HT4 receptor activation on animals undergoing chronic cannabinoid exposure during adolescence
    Oualid Abboussi, Nadia Said, Karim Fifel, Sara Lakehayli, Abdelouahhab Tazi, Soumaya El Ganouni · 2015 · Metabolic Brain Disease
95. Discovery of amide based fibrates as possible antidyslipidemic and antioxidant agents
    Koneni V. Sashidhara, Gopala Reddy Palnati, Ranga Prasad Dodda, Ravi Sonkar, A. Khanna, Gitika Bhatia · 2012 · European Journal of Medicinal Chemistry
96. Naturally Inspired Molecules as Multifunctional Agents for Alzheimer’s Disease Treatment
    Angela Rampa, Andrea Tarozzi, Francesca Romana Mancini, Letizia Pruccoli, Rita Maria Concetta Di Martino, Silvia Gobbi, Alessandra Bisi, Angela De Simone, Francesco Palomba, Nelsi Zaccheroni et al. · 2016 · Molecules
97. Alignment-independent 3D-QSAR and molecular docking studies of tacrine−4-oxo-4H-Chromene hybrids as anti-Alzheimer's agents
    Elham Manouchehrizadeh, Azar Mostoufi, Elham Tahanpesar, Masood Fereidoonnezhad · 2019 · Computational Biology and Chemistry
98. Potentiating the Benefits of Melatonin through Chemical Functionalization: Possible Impact on Multifactorial Neurodegenerative Disorders
    Annia Galano, Eduardo Gabriel Guzmán‐López, Russel Joseph Reiter · 2021 · International Journal of Molecular Sciences
99. Evaluation of 4-aminoquinoline derivatives with an n-octylamino spacer as potential multi-targeting ligands for the treatment of Alzheimer's disease
    Ana Matošević, Dejan Opsenica, Marta Spasić, Nikola Maraković, Antonio Zandona, Suzana Žunec, Marija Bartolić, Zrinka Kovarik, Anita Bosak · 2023 · Chemico-Biological Interactions
100. Conceptual Framework of the Design of Pleiotropic Drugs against Alzheimer’s Disease
     Thomas Guiselin, Cédric Lecoutey, Christophe Rochais, Patrick Dallemagne · 2023 · Pharmaceutics